Full Episode
Saturday, Mar 25
PBS NewsHour
  • Episodes
  • Podcasts
  • Newsletters
  • The Latest
  • Politics
    Politics
    • Brooks and Capehart
    • Politics Monday
    • Supreme Court
  • Arts
    Arts
    • CANVAS
    • Poetry
    • Now Read This
  • Nation
    Nation
    • Supreme Court
    • Race Matters
    • Essays
    • Brief But Spectacular
  • World
    World
    • Agents for Change
  • Economy
    Economy
    • Making Sen$e
    • Paul Solman
  • Science
    Science
    • The Leading Edge
    • ScienceScope
    • Basic Research
    • Innovation and Invention
  • Health
    Health
    • Long-Term Care
  • Education
    Education
    • Teachers' Lounge
    • Student Reporting Labs
  • For Teachers
    Education
    • Newshour Classroom
  • NewsHour Shop
  • About
    • Feedback
    • Funders
    • Support
    • Jobs

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

Nation
PBS NewsHour

Get news alerts from PBS NewsHour

Turn on desktop notifications?

Marilynn Marchione, AP Chief Medical Writer

  • Full Episodes
  • Podcasts
  • Newsletters
  • Live

Marilynn’s Recent Stories

Health Jan 21

FDA approves 1st long-acting HIV drug combo

It's expected to make it easier for people to stay on track with their HIV medicines and to do so with more privacy. Not long ago, patients had to take multiple pills several times a day to control infection with…

Politics Nov 20

Trump makes late-term bid to lower prescription drug costs

Trying to close out major unfinished business, the Trump administration issued regulations Friday that could lower the prices Americans pay for many prescription drugs.

Health Nov 06

FDA panel urges rejection of experimental Alzheimer’s drug

The panel of outside experts for the Food and Drug Administration agreed that a pivotal study in patients failed to show “strong evidence” that the drug worked.

Health Oct 22

FDA approves first COVID-19 drug

Its maker, Gilead Sciences Inc., said Thursday that the drug is approved for people at least 12 years old who need hospitalization for their coronavirus infection.

Health Sep 27

Nearly 1M who died of COVID-19 also illuminated treatment

The nearly 1 million people around the world who have lost their lives to COVID-19 have left us a gift: Through desperate efforts to save their lives, scientists now better understand how to treat and prevent the disease — and…

Health Aug 24

Scientists say Hong Kong man became infected with coronavirus a second time

"That's a win as far as I'm concerned" because it suggests a first infection may protect a person from moderate to severe disease the second time around, a vaccine expert said.

Health Jul 01

Some health experts criticize U.S. mass purchase of licensed virus drug

The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to Americans for the next three months.

Nation Jun 25

As many as 20 million in U.S. have had COVID-19, officials say — 10 times more than previously thought

U.S. officials believe as many as 20 million Americans have contracted the coronavirus since it first arrived in the country. That's nearly 10 times as many infections as the 2.3 million cases that have been confirmed so far.

Health Jun 16

Drug dexamethasone provides first evidence of improving COVID-19 survival

Researchers in England say they have the first evidence that a drug can improve COVID-19 survival: A cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients.

Health Jun 04

Study on safety of malaria drugs for coronavirus retracted

Several authors of a large study that raised safety concerns about malaria drugs for coronavirus patients have retracted the report. They say independent reviewers weren't able to verify information that's been widely questioned by other scientists.

Jump to the First Page Previous Page
1 2 3
Next Page Jump to the Last Page

Support Provided By: Learn more

Educate your inbox

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

Form error message goes here.

Thank you. Please check your inbox to confirm.

PBS NewsHour

© 1996 - 2023 NewsHour Productions LLC. All Rights Reserved.

Sections

  • The Latest
  • Politics
  • Arts
  • Nation
  • World
  • Economy
  • Science
  • Health
  • Education

About

  • About Us
  • TV Schedule
  • Press
  • Feedback
  • Funders
  • Support
  • Newsletters
  • Podcasts
  • Jobs
  • Privacy

Stay Connected

  • Facebook
  • Twitter
  • YouTube
  • RSS

Subscribe to ‘Here's the Deal,’ our politics newsletter

Form error message goes here.

Thank you. Please check your inbox to confirm.

Support our journalism

Learn more about Friends of the NewsHour.

Support for NewsHour Provided By

  • BDO
  • BNSF Railway
  • Consumer Cellular
  • Corporation for Public Broadcasting
  • Fidelity
  • Viewers Like You